Document is current
Any future updates will be listed below
-
Authors
Callens, Céline
Driouch, Keltouma
Boulai, Anaïs
Tariq, Zakia
Comte, Aurélie
Berger, Frédérique
Belin, Lisa
Bièche, Ivan
Servois, Vincent
Legoix, Patricia
Bernard, Virginie
Baulande, Sylvain
Chemlali, Walid
Bidard, François-Clément
Fourchotte, Virginie
Salomon, Anne Vincent-
Brain, Etienne
Lidereau, Rosette
Bachelot, Thomas
Saghatchian, Mahasti
Campone, Mario
Giacchetti, Sylvie
Zafrani, Brigitte Sigal
Cottu, Paul https://orcid.org/0000-0001-6434-3932
- License Information
-
More Information
Article History
Received: 30 November 2020
Accepted: 25 February 2021
First Online: 15 March 2021
Declarations
:
: This study was approved by the French Ethics Committee (“Comité de Protection des Personnes”) and the Institutional Reviews Boards of participating centers. All patients have given their written informed consent. This trial was registered at (NCT01956552). The ESOPE study was approved by the Institut Curie Review Board and Ethics Committee (reference number: 2010-A00781–56). Other participating centers were as follows: Gustave Roussy Institute, Villejuif, France; Saint-Louis Hospital, Paris, France; René Gauducheau Cancer Center, Saint-Herblain, France; Léon Bérard Cancer Center, Lyon, France. All institutional review boards approved the study. The research was conducted in strict compliance with the Helsinki Declaration.
: Not applicable.
: The authors declare that they have no competing interests.
